U.S. stock-index futures turned positive on Friday after a report from Gilead Sciences indicated that its experimental treatment for coronavirus was seeing positive results in reducing deaths. Futures for the Dow Jones Industrial Average
YM00,
+0.05%
YMU20,
+0.05%
were up 0.1% at 25,600, those for the S&P 500 index
ES00,
-0.19%
ESU20,
-0.19%
were trading up 0.1% at 3,144, while Nasdaq-100 futures
NQ00,
-0.64%
NQU20,
-0.64%
advanced 0.1% at 10,740. Gilead published a report on Friday saying that its antiviral drug remdesivir showed that it reduced the risk of death for coronavirus patients by 62% compared with standard care alone.

The findings are being presented at the Virtual Covid-19 Conference as part of the 23rd International AIDS Conference, the company said.